Trial Profile
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Talimogene laherparepvec (Primary) ; Talimogene laherparepvec (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 19 Jun 2023 Status changed from active, no longer recruiting to completed.
- 15 Mar 2019 Planned End Date changed from 1 Apr 2020 to 16 Oct 2023.
- 15 Mar 2019 Status changed from recruiting to active, no longer recruiting.